期刊文献+

红细胞生成素及受体在脑肿瘤中的表达 被引量:2

Expression of erythropoietin and it's receptor in brain tumor
原文传递
导出
摘要 红细胞生成素(erythropoietin,EPO)是调节红细胞生成的细胞因子.近年来研究发现.多种非红细胞生成组织表达红细胞生成素受体(erythropoietinreceptor,EPOR),提示EPO具有多种生物活性.有可能成为抗肿瘤细胞增殖治疗及抗血管生成治疗的靶点。Epo在各种肿瘤中的作用逐渐成为研究的热点,尤其近年脑肿瘤的研究渐多,现将EPO及受体在脑肿瘤中的表达进行综述。
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2009年第9期967-968,972,共3页 Chinese Journal of Neuromedicine
关键词 红细胞生成素 红细胞生成素受体 重组红细胞生成素 脑肿瘤 Erythropoietin Erythropoietin receptor Recombinant human crythropoietin Brain tumor
  • 相关文献

参考文献19

  • 1Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin[J]. JAMA, 2005, 293(1): 90-95.
  • 2Hardee ME, Arcasoy MO, BlackweU KL, et al. Erythropoietin biology in cancer[J]. Clin Cancer Res, 2006, 12(2): 332-339.
  • 3Leyland-Jones B, Semiglazov V, Pawlicki M, et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study[J]. J Clin Oncol, 2005, 23(25): 5960-5972.
  • 4Wan T, Law L, Harvey D, et al. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin[J]. Cancer, 2003, 98(7): 1514-1520.
  • 5Kjellen E, Sasaki Y, Kjellstrom J, et al. Recombinant erythropoietin beta enhances growth of xenografted human squamous cell carcinoma of the head and neck after surgical trauma [J]. Acta Otolaryngol, 2006, 126(5): 545-547.
  • 6LaMontagne KR, Butler J, Marshall DJ, et al. Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models [J]. Mol Cancer Ther, 2006, 5(2): 347-355.
  • 7Marti HH. Erythropoietin and the hypoxic brain[J]. J Exp Biol, 2004, 207(Pt 18): 3233-3242.
  • 8Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury [J]. Proc Natl Acad Sci U S A, 2000, 97(19): 10526-10531.
  • 9Mohyeldin A, Dalgard CL, Lu H, et al. Survival and invasiveness of astrocytomas promoted by erythropoietin[J]. J Neurosurg, 2007, 106(2): 338-350.
  • 10Mittelbronn M, Capper D, Bunz B, et al. De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival[J]. Neuropathol Appl Neurobiol, 2007, 33(3): 299-307.

同被引文献17

  • 1董鹏,王滨,孙西河,常光辉,李绪斌,陈静静.肺癌脑转移瘤瘤周水肿程度的影响因素研究[J].中国医学影像技术,2006,22(1):57-59. 被引量:20
  • 2Schallert T.Behavioral tests for preclinical intervention assessment[J].Neuro Rx,2006,3(4):497-504.
  • 3Vorhees CV,Williams MT.Morris water maze:procedures for assessing spatial and related forms of learning and memory[J].Nat Protoc,2006,1(2):848-858.
  • 4Mammis A,Mclntosb TK,Maniker AH.Erythropoietin as a neuroprotective agent in traumatic brain injury Review[J].Surg Neurol,2009,71(5):527-531.
  • 5Gonzalez FF,Abel R,Almli CR,et al.Erythropoietin sustains cognitive function and brain volume after neonatal stroke[J].Dev Neurosci,2009,31(5):403-411.
  • 6Lu D,Mahmood A,Qu C,et al.Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury[J].J Neurotrauma,2005,22(9):1011-1017.
  • 7Grasso G,Sfacteria A,Meli F,et al.Neuroprotection by erythropoietin administration after experimental traumatic brain injury[J].Brain Res,2007,1182:99-105.
  • 8Xiong Y,Lu D,Qu C,et al.Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice[J].J Neurosurg,2008,109(3):510-521.
  • 9Xiong Y,Mahmood A,Lu D,et al.Role of gender in outcome after traumatic brain injury and therapeutic effect of erythropoietin in mice[J].Brain Res,2007,1185:301-312.
  • 10Xiong Y,Mahmood A,Lu D,et al.Histological and functional outcomes after traumatic brain injury in mice null for the erythropoietin receptor in the central nervous system[J].Brain Res,2008,1230:247-257.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部